| By Cindy Wu, Asia Manufacturing Pharma |
| Monday, 12 October 2009 |
 |
China’s foreign trade in medicines totaled US$18.4 billion for the first seven months of this year, up
|
|
12.3 percent when compared to the corresponding period last year, with imports and exports rising 19 percent and 8 percent to US$7.6 billion and US$10.8 billion respectively, despite the double-digit decline in the country’s foreign trade market arising from the worldwide financial downturn.
Chemical active pharmaceutical ingredients (APIs) and medical equipment remain the top two products in the Chinese
|
|
|
pharmaceutical industry in terms of foreign trade, with their respective numbers reaching US$3.3 billion and US$3.2 billion in the first seven months, accounting for 33 percent and 32 percent of the total. In addition, foreign trade in chemical preparations amounted to US$1.4 billion, making up 7.9 percent of the total.
Specifically, imports of medical equipment, APIs and chemical preparations were US$2.9 billion, US$1.2 billion and US$1.1billion, representing 21 percent, 16 percent and 14.5 percent respectively of the total, while exports of chemical APIs and medical equipment were US$4.9 billion and US$3 billion, accounting for 45.6 percent and 28 percent
|
|
respectively of the total.
In July, imports of the top ten import products in the pharmaceutical sector totaled US$216 million, accounting for 18 percent of the total imports, while exports of top ten export products in the sector totaled US$367 million, making up 20.8 percent of the total exports.
Want to read more?
Chongqing Lummy Pharmaceutical plans to raise capital for establishing manufacturing base through an IPO
Chinese drugmakers expanding capabilities in Azithromycin APIs
Chinese pharmaceutical manufacturers begin shift to downstream products |
|
|
